Fukushima J. Med. Sci., Vol. 56, No. 2, 2010

[Original Article]

HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE DEPARTMENT OF HEMATOLOGY, FUKUSHIMA MEDICAL UNIVERSITY

KAZUEI OGAWA¹⁾, HIDEYOSHI NOJI¹⁾, MIKI FURUKAWA¹⁾, KAYO HARADA-SHIRADO¹⁾, YUMIKO MASHIMO¹⁾, HIROSHI TAKAHASHI¹⁾, HAYATO MATSUMOTO¹⁾, SATOSHI KIMURA¹⁾, AKIKO SHICHISHIMA-NAKAMURA¹⁾, HIROSHI OHKAWARA¹⁾, KAZUHIKO IKEDA¹⁾, HITOSHI OHTO²⁾ and YASUCHIKA TAKEISHI¹⁾

¹⁾Department of Cardiology and Hematology, Fukushima Medical University, Fukushima, Japan, ²⁾Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University, Fukushima, Japan

(Received August 10, 2010, accepted October 26, 2010)

Abstract: From 1996 to the end of 2009, a total of 114 cases of hematopoietic stem cell transplantation were performed in the Department of Hematology, Fukushima Medical University. We report here a general overview of our results. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) was performed in 37 cases of acute leukemia, 10 of myelodysplastic syndrome, 5 of aplastic anemia, and 5 others. The 5-year survival rate with allo-HSCT was 51.1%. Autologous hematopoietic stem cell transplantation (auto-HSCT) was performed in 34 cases of malignant lymphoma, 15 of multiple myeloma, and 8 others. The 5-year patient survival rate was 75.2% with malignant lymphoma and 46.7% with multiple myeloma. These results are comparable to those from a nationwide survey in Japan, confirming that our hospital has attained a creditable level as a transplantation center.

Key words: Allogenic stem cell transplantation, Autologous stem cell transplantation, Survival curves

小川一英，野地秀義，古川未希，原田佳代，眞下由美子，高橋裕志，松本勇人，木村　哲，七島晶子，大河原浩，池田和彦，大戸　斉，竹石恭知

Corresponding author: Kazuei Ogawa, MD, PhD
E-mail address: kogawa@fmu.ac.jp
http: //www.jstage.jst.go.jp/browse/fms
http: //fmu.ac.jp/home/lib/F-igaku/